Biocon files Prospectus for Syngene IPO

Under the proposed issue, shares will be offered through an offer for sale (OFS) route by Biocon Limited upto 22,000,000 equity shares of face value of Rs. 10 each for cash and at such premium as may be determined. The offer includes a reservation of 2,000,000 Equity Shares for Biocon Shareholders.

Apr 23, 2015 08:04 IST India Infoline News Service

Biocon Limited
Biocon Ltd has announced that Syngene international Limited, a subsidiary of the Company has proposed public issue of its equity shares through 100% book building method in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 and has filed a Draft Red Herring Prospectus with the Securities and Exchange Board of India on April 22, 2015.
Under the proposed issue, shares will be offered through an offer for sale (OFS) route by Biocon Limited upto 22,000,000 equity shares of face value of Rs. 10 each for cash and at such premium as may be determined. The offer includes a reservation of 2,000,000 Equity Shares for Biocon Shareholders.

Related Story

Blogs & Personal Finance